AscellaHealth Europe’s Post

What Can Clinical Researchers Learn From Commercial Product Launches? Most launches (both trial and product) fail because we’re still playing by old rules. In pharma, we think a new drug or clinical trial “launch” is the finish line, but it's just the starting gun. And yet, 80% of trials run late, and two-thirds of drugs flop in their first year. Why? We haven't evolved. We're not adapting to the nuanced reality of today’s drug development landscape. Patient enrollment and engagement aren’t side notes—they’re the heart of the process. If you’re ready to rethink what it means to truly launch, this article is your blueprint. It’s time to shift gears... Read part 1 of 3 of our full analysis at https://lnkd.in/dEZA6ziC

🚀 Exciting Update: Zymewire's Q2 2024 Recap is Here! 🚀 Curious about the latest trends in clinical trials for Q2? We've got the insights you're looking for! 📊✨ 🔍 Check out the snapshot below for a quick look at planned clinical trials in North America. The trends are holding steady with last quarter, but there's a lot more to uncover: Which trials are backed by well-funded sponsors? Which therapeutic areas are faring better than others? 👉 If you are a pharma/biotech service provider, dive into our latest blog to help inform smarter business decisions going forward: https://lnkd.in/gtmBw5Jf DM or email at amarpreet.singh@zymewire.com to learn more. #ClinicalTrials #PharmaTrends #Pharma #Drugsponsors

Data analysis is crucial in the biopharma industry, impacting decision-making throughout the drug discovery, clinical trials, and marketing stages. The shift towards #precisionmedicine and targeted therapies has increased the importance of data analysis, allowing for better understanding of patient characteristics and drug responses. Data analysis in the biopharma industry isn't just about numbers—it's the key to unlocking life-saving treatments. #OBI4You #DataDrivenHealthcare https://zurl.co/LXae

Watch the replay and embrace the power of GenAI in Pharma. Discover how it can revolutionize drug development, ensuring better outcomes for patients and providers. #AWSreInvent

Watch the replay and embrace the power of GenAI in Pharma. Discover how it can revolutionize drug development, ensuring better outcomes for patients and providers. #AWSreInvent

The #pharmasupplychain do have a high level of complexity and #digitalbusinesstransformation is a key component to eliminate that complexity. #clinicaltrials is even more complex. See in below post and linked article, how #Controlant tackles this topic.

What Can Clinical Researchers Learn From Commercial Product Launches? 𝗔 𝟯 𝗽𝗮𝗿𝘁 𝘀𝗲𝗿𝗶𝗲𝘀 𝗶𝗻 Clinical Leader 𝗥𝗲𝗮𝗱 𝗽𝗮𝗿𝘁 𝟭 𝗼𝗳 𝟯 𝗵𝗲𝗿𝗲 - https://lnkd.in/eYnMvQPp 𝗦𝘂𝗺𝗺𝗮𝗿𝘆 Most launches (both trial and product) fail because we’re still playing by old rules. In pharma, we think a new drug or clinical trial “launch” is the finish line, but it's just the starting gun. And yet, 80% of trials run late, and two-thirds of drugs flop in their first year. Why? We haven't evolved. We're not adapting to the nuanced reality of today’s drug development landscape. Patient enrollment and engagement aren’t side notes—they’re the heart of the process. If you’re ready to rethink what it means to truly launch, this article is your blueprint. It’s time to shift gears... Follow 🔔 Liam Eves to find out more about clinical trials.

How can the #pharma industry best prepare for the clinical trial #supplychain evolution that is already underway? With more novel therapies, decentralization, and ambitious sustainability goals, the industry is finding solutions in #digitaltransformation, where data-driven decision-making based on real-time visibility puts them in control of optimizing the supply chain every step of the way. Read more here https://lnkd.in/dgiMhN6W

Watch the replay and embrace the power of GenAI in Pharma. Discover how it can revolutionize drug development, ensuring better outcomes for patients and providers. #AWSreInvent

Watch the replay and embrace the power of GenAI in Pharma. Discover how it can revolutionize drug development, ensuring better outcomes for patients and providers. #AWSreInvent